The gynecomastia treatment market is growing as awareness of the condition improves, social stigma declines, and more patients seek medical or aesthetic solutions. The market was valued at USD 8.7 billion in 2024 and is projected to reach USD 13.23 billion by 2032, expanding at a CAGR of 5.39%. Growth is supported by increasing prevalence linked to hormonal imbalances, obesity, aging, certain medications, and rising demand for cosmetic procedures.wiseguyreports

Gynecomastia refers to enlargement of breast tissue in males. It can occur at different life stages, including adolescence and later adulthood, and may be associated with hormonal changes, obesity, medication use, or other health conditions. The growing recognition that gynecomastia can affect physical comfort, body image, and psychological well-being is increasing the number of people seeking professional evaluation and treatment.

Surgical treatment remains the largest market segment. It was valued at USD 6.2 billion in 2024 and is expected to reach USD 9.2 billion by 2032. Surgical options include liposuction and mastectomy or gland excision, depending on the severity of the condition and the patient’s clinical situation. Liposuction is widely used in mild to moderate cases involving fatty tissue, while more extensive procedures may be considered where glandular tissue needs to be addressed.wiseguyreports

The market is shifting toward minimally invasive techniques. Laser-assisted liposuction, ultrasonic aspiration, laser lipolysis, and other advanced technologies are gaining interest because they may reduce scarring, shorten recovery periods, and improve precision. Three-dimensional planning and computer-aided design tools are also supporting more personalized surgical approaches.

Non-surgical treatments are expected to grow faster than surgical treatments, with a projected CAGR of 5.9%. This segment includes medication, lifestyle modifications, and less invasive technologies such as cryolipolysis and radiofrequency-based approaches. Drug categories discussed in the report include tamoxifen, clomiphene, letrozole, anastrozole, and exemestane. Treatment decisions should be based on clinical evaluation of the individual’s underlying cause, symptoms, and overall health.

North America is the largest regional market, accounting for more than 40% of global revenue, supported by advanced aesthetic-care infrastructure, rising awareness, and the presence of major treatment providers. Europe is the second-largest market, while Asia-Pacific is expected to grow through higher disposable income, increased healthcare access, and growing acceptance of cosmetic and minimally invasive procedures.

Companies active in the market include Galderma, Allergan, Merz Pharmaceuticals, Johnson & Johnson, Sanofi, Novartis, Teva Pharmaceutical Industries, Pfizer, Bayer, Roche, and GlaxoSmithKline. The market’s future will depend on treatment innovation, patient education, affordability, and continued demand for less invasive approaches.wiseguyreports

Read more: Gynecomastia Treatment Market

People Also Ask

Q1. What are the major treatment approaches for gynecomastia?
Treatment categories include surgical procedures, non-surgical interventions, medication, and lifestyle-focused management depending on the patient’s individual clinical situation.

Q2. Why are minimally invasive gynecomastia procedures growing?
They are gaining attention because they can offer improved precision, lower scarring, and potentially shorter recovery periods than traditional techniques.

Tags: gynecomastia treatment market, male breast reduction, liposuction, minimally invasive cosmetic surgery, gynecomastia awareness